n-methylscopolamine has been researched along with Esophageal Reflux in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, JC; Liu, J; Mittal, RK; Sarosiek, I; Yamamoto, Y | 1 |
| Levine, DS; Mulholland, MW; Reid, BJ; Rubin, CE | 1 |
1 trial(s) available for n-methylscopolamine and Esophageal Reflux
| Article | Year |
|---|---|
Cholinergic blockade inhibits gastro-oesophageal reflux and transient lower oesophageal sphincter relaxation through a central mechanism.
Topics: Adult; Atropine; Cholinergic Antagonists; Esophagogastric Junction; Esophagus; Female; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Manometry; Middle Aged; Muscle Relaxation; N-Methylscopolamine; Parasympatholytics; Peristalsis; Pressure | 1999 |
1 other study(ies) available for n-methylscopolamine and Esophageal Reflux
| Article | Year |
|---|---|
Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium.
Topics: Barrett Esophagus; Chronic Disease; Cimetidine; Female; Gastric Acid; Gastric Acidity Determination; Gastrins; Gastroesophageal Reflux; Humans; Male; Middle Aged; Monitoring, Physiologic; N-Methylscopolamine; Parasympatholytics; Scopolamine Derivatives | 1989 |